Opportunity Information: Apply for PAR 18 717
The Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) is a National Institutes of Health (NIH) discretionary grant opportunity designed to build durable HIV research training capacity within low- and middle-income country (LMIC) institutions. The central aim is to support structured research training programs that strengthen the scientific workforce and institutional systems needed to conduct high-quality HIV research that matches the realities of an evolving epidemic in the applicant country. In practical terms, the program is meant to help LMIC institutions develop or expand their ability to train researchers, generate locally relevant evidence, and sustain independent research activity over time, rather than relying solely on external partners.
This opportunity is issued under Funding Opportunity Announcement (FOA) number PAR-18-717 and uses the D43 mechanism, which NIH commonly uses for international research training programs. The designation "Clinical Trial Optional" means the training program may include clinical trial-related research experiences or components when appropriate, but a clinical trial is not required for the application to be responsive. The funding activity category is listed under education and health, reflecting that the primary deliverable is training and capacity building, not only research outputs.
Applications may be submitted by a broad set of organizational types, including public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (both with and without 501(c)(3) status). The announcement also explicitly highlights additional eligible applicants such as Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and non-domestic (non-U.S.) entities, including foreign organizations. This emphasis signals NIH's interest in supporting partnerships and eligible lead institutions that can meaningfully contribute to LMIC-centered capacity strengthening, whether the applicant organization is based in the U.S. or abroad, so long as the proposed program advances LMIC institutional scientific capacity.
The opportunity was created on March 21, 2018, with an original closing date of August 23, 2018. The listed award ceiling is $280,000, indicating an upper limit on the budget size NIH expected to support per award (as presented in the source data). The announcement references multiple CFDA numbers (93.242, 93.273, 93.279, 93.398, 93.989), which correspond to NIH program areas that may be involved in funding or administering aspects of the program and reflect NIH's multi-institute structure.
Overall, the program focuses on developing research training that is directly relevant to the HIV epidemic and research priorities in the LMIC context, with the broader goal of enabling LMIC institutions to lead, implement, and sustain rigorous HIV research. This typically implies building human capital (trainees and mentors), strengthening research training curricula and mentorship structures, and enhancing institutional capabilities that support research productivity and long-term independence, all aligned to local public health needs and the changing dynamics of HIV.Apply for PAR 18 717
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.273, 93.279, 93.398, 93.989.
- This funding opportunity was created on 2018-03-21.
- Applicants must submit their applications by 2018-08-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $280,000.00 in funding.
- Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)?
It is an NIH discretionary grant opportunity designed to build durable HIV research training capacity within low- and middle-income country (LMIC) institutions. The program supports structured research training that strengthens the scientific workforce and institutional systems needed to conduct high-quality HIV research that aligns with the realities of an evolving epidemic in the applicant country.
What is the main goal of this grant opportunity?
The central aim is to support research training programs that enable LMIC institutions to develop or expand their ability to train researchers, generate locally relevant evidence, and sustain independent HIV research activity over time, rather than depending primarily on external partners.
What is the FOA number for this opportunity?
The Funding Opportunity Announcement (FOA) number is PAR-18-717.
What NIH grant mechanism does this opportunity use?
This opportunity uses the D43 mechanism, which NIH commonly uses for international research training programs.
What does "Clinical Trial Optional" mean in this announcement?
"Clinical Trial Optional" means the proposed training program may include clinical trial-related research experiences or components when appropriate, but a clinical trial is not required for an application to be considered responsive.
What is the funding activity category for this program?
The funding activity category is listed under education and health, reflecting that the primary deliverable is training and capacity building, not only research outputs.
Who is eligible to apply?
A broad set of organizational types may apply, including public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (both with and without 501(c)(3) status). The announcement also highlights additional eligible applicants such as Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and non-domestic (non-U.S.) entities, including foreign organizations.
Can a non-U.S. (foreign) organization apply as the lead applicant?
Yes. The announcement explicitly includes non-domestic (non-U.S.) entities, including foreign organizations, among eligible applicants.
Does NIH expect U.S.-based organizations to be involved?
The eligibility language signals NIH interest in supporting partnerships and eligible lead institutions that can meaningfully contribute to LMIC-centered capacity strengthening, whether the applicant is based in the U.S. or abroad, as long as the proposed program advances LMIC institutional scientific capacity.
What types of institutions are emphasized as eligible in the announcement?
In addition to higher education institutions and nonprofits, the announcement explicitly highlights Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and non-U.S. entities (foreign organizations) as eligible applicants.
What kinds of activities is this program intended to support?
The program is intended to support structured HIV research training and capacity building within LMIC institutions. This typically implies building human capital (trainees and mentors), strengthening research training curricula and mentorship structures, and enhancing institutional capabilities that support research productivity and long-term independence, aligned with local public health needs and changing HIV dynamics.
Is the focus more on research results or training and capacity building?
The focus is primarily on training and capacity building. While research experiences may be part of the training program, the core deliverable is strengthening the workforce and institutional systems needed to conduct high-quality HIV research over the long term.
What does "durable HIV research training capacity" mean in the context of this opportunity?
It refers to developing long-lasting training programs and institutional systems that allow an LMIC institution to continually develop researchers and sustain independent HIV research activity over time, rather than relying mainly on external partners.
How should the training program relate to the HIV epidemic in the applicant country?
The training program is intended to match the realities and priorities of an evolving HIV epidemic in the applicant country and support research training that is directly relevant to the LMIC context.
When was this funding opportunity created?
The opportunity was created on March 21, 2018.
What was the original closing date listed for this opportunity?
The original closing date was August 23, 2018.
What is the award ceiling for this opportunity?
The listed award ceiling is $280,000, indicating an upper limit on the budget size NIH expected to support per award (as presented in the source data).
Which CFDA numbers are referenced in the announcement?
The announcement references CFDA numbers 93.242, 93.273, 93.279, 93.398, and 93.989.
Why are multiple CFDA numbers listed?
The multiple CFDA numbers correspond to NIH program areas that may be involved in funding or administering aspects of the program and reflect NIH's multi-institute structure.
What is NIH trying to enable LMIC institutions to do through this program?
The broader goal is to enable LMIC institutions to lead, implement, and sustain rigorous HIV research by strengthening researchers, mentorship, training structures, and institutional support systems aligned to local needs.
Browse more opportunities from the same category: Education, Health
Next opportunity: The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed)
Previous opportunity: U.S. EMBASSY ANKARA Public Affairs Grant Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 717
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 717) also looked into and applied for these:
| Funding Opportunity |
|---|
| Workshop on the Use of Adolescent Brain Cognitive Development (ABCD) Data (R25 Clinical Trial Not Allowed) Apply for RFA DA 19 006 Funding Number: RFA DA 19 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) Apply for PA 18 723 Funding Number: PA 18 723 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) Apply for PA 18 722 Funding Number: PA 18 722 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Apply for PAR 18 731 Funding Number: PAR 18 731 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). Apply for PA 18 738 Funding Number: PA 18 738 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). Apply for PA 18 739 Funding Number: PA 18 739 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional) Apply for RFA CA 18 024 Funding Number: RFA CA 18 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional) Apply for RFA CA 18 022 Funding Number: RFA CA 18 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional) Apply for RFA CA 18 021 Funding Number: RFA CA 18 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional) Apply for PAR 18 742 Funding Number: PAR 18 742 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional) Apply for RFA CA 18 023 Funding Number: RFA CA 18 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) Apply for PAR 18 746 Funding Number: PAR 18 746 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 748 Funding Number: PA 18 748 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Apply for PAR 18 764 Funding Number: PAR 18 764 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) Apply for PAR 18 767 Funding Number: PAR 18 767 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional) Apply for PA 18 775 Funding Number: PA 18 775 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) Apply for PA 18 774 Funding Number: PA 18 774 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional) Apply for PA 18 776 Funding Number: PA 18 776 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) Apply for PA 18 773 Funding Number: PA 18 773 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21 Clinical Trial Not Allowed) Apply for RFA CA 18 014 Funding Number: RFA CA 18 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 717", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.